Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study-Reference-Cited by-同舟云学术

Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study

Published:2013 Issue:2 Volume:17 Page:R59
ISSN:1364-8535
Container-title:Critical Care
language:en
Short-container-title:Critical Care

Author:

Rimmelé Thomas,Kaynar Ata,McLaughlin Joseph N,Bishop Jeffery V,Fedorchak Morgan V,Chuasuwan Anan,Peng Zhiyong,Singbartl Kai,Frederick Daniel R,Zhu Lin,Carter Melinda,Federspiel William J,Zeevi Adriana,Kellum John A

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Reference38 articles.

1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

2. Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock

3. International Differences in the Treatment of Sepsis

4. Activated protein C and hospital mortality in septic shock: A propensity-matched analysis*

5. Does recombinant activated protein C work in patients with severe sepsis?*

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteins Adsorbed during Intraoperative Hemoadsorption and Their In Vitro Effects on Endothelium;Healthcare;2023-01-19

2. Comparison of outcomes and costs of extracorporeal blood purification therapies in critically ill COVID ‐19 patients;Therapeutic Apheresis and Dialysis;2022-11-21

3. Cellular Immuno-Profile in Septic Human Host: A Scoping Review;Biology;2022-11-07

4. New Targets for Extracorporeal Blood Purification Therapies in Sepsis;Blood Purification;2022-06-17

5. Effects of Continuous Blood Purification without Heparin on Strem-1, NSE, and IL-10 Levels in Patients with Sepsis;Cellular and Molecular Biology;2022-04-30